|
Late last month the Allos drug called "RSR-13" was denied acceptance by the FDA for being inneffectual except for a subset of patients. These patients were Metestatic BC patients who later developed brain mets.
The FDA has allowed Allos to further investigate the effectiveness of this drug. Trials are being held throughout the US and Canada. Hugs Christine |
| All times are GMT -7. The time now is 02:22 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021